Thru Pharma LLC acquired Kasten, Inc. (OTCPK:KAST) in a reverse merger transaction on March 7, 2017. As consideration, 42 million shares of Kasten were issued to Thru Pharma LLC. Concurrent with the merger, Kasten, Inc. reduced the number of shares outstanding from 127.5 million shares to 62.5 million shares. Thru Pharma LLC completed the acquisition of Kasten, Inc. (OTCPK:KAST) in a reverse merger transaction on March 7, 2017.